Topiramate and panic attacks in patients with borderline personality disorder.
Clivaz
E
E
Chauvet
I
I
Zullino
D
D
Niquille
M
M
Maris
S
S
Cicotti
A
A
Lazignac
C
C
Lazignac Coralie
C
C
Damsa
C
C
D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001883:Borderline Personality Disorder / Q000150:complications*; D004632:Emergency Medical Services; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000009:adverse effects*; D016584:Panic Disorder / Q000139:chemically induced* / Q000523:psychology*; D000077236:Topiramate
D014151:Anti-Anxiety Agents; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose; D008140:Lorazepam